X, X., MD, W., JH, X., ZQ, F., YK, D., Z, C., . . . T, Y. (2024). Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis. Frontiers in immunology, 14, 1322233. https://doi.org/10.3389/fimmu.2023.1322233
Chicago Style (17th ed.) CitationX, Xu, et al. "Adjuvant Immunotherapy Improves Recurrence-free and Overall Survival Following Surgical Resection for Intermediate/advanced Hepatocellular Carcinoma a Multicenter Propensity Matching Analysis." Frontiers in Immunology 14 (2024): 1322233. https://doi.org/10.3389/fimmu.2023.1322233.
MLA (9th ed.) CitationX, Xu, et al. "Adjuvant Immunotherapy Improves Recurrence-free and Overall Survival Following Surgical Resection for Intermediate/advanced Hepatocellular Carcinoma a Multicenter Propensity Matching Analysis." Frontiers in Immunology, vol. 14, 2024, p. 1322233, https://doi.org/10.3389/fimmu.2023.1322233.